- Home
- ENIC vs QURE Comparison
ENIC vs QURE Comparison
Compare ENIC & QURE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ENIC
- QURE
- Stock Information
- Founded
- ENIC 2016
- QURE 1998
- Country
- ENIC Chile
- QURE Netherlands
- Employees
- ENIC N/A
- QURE N/A
- Industry
- ENIC Electric Utilities: Central
- QURE Biotechnology: Pharmaceutical Preparations
- Sector
- ENIC Utilities
- QURE Health Care
- Exchange
- ENIC Nasdaq
- QURE Nasdaq
- Market Cap
- ENIC 5.2B
- QURE 4.3B
- IPO Year
- ENIC N/A
- QURE 2007
- Fundamental
- Price
- ENIC $3.85
- QURE $30.76
- Analyst Decision
- ENIC Hold
- QURE Strong Buy
- Analyst Count
- ENIC 2
- QURE 13
- Target Price
- ENIC $3.90
- QURE $62.33
- AVG Volume (30 Days)
- ENIC 486.3K
- QURE 4.6M
- Earning Date
- ENIC 10-29-2025
- QURE 11-10-2025
- Dividend Yield
- ENIC 4.84%
- QURE N/A
- EPS Growth
- ENIC N/A
- QURE N/A
- EPS
- ENIC 0.00
- QURE N/A
- Revenue
- ENIC $3,760,459,463.00
- QURE $15,751,000.00
- Revenue This Year
- ENIC $114,797.03
- QURE N/A
- Revenue Next Year
- ENIC N/A
- QURE $229.18
- P/E Ratio
- ENIC $93.71
- QURE N/A
- Revenue Growth
- ENIC N/A
- QURE N/A
- 52 Week Low
- ENIC $2.62
- QURE $5.50
- 52 Week High
- ENIC $4.05
- QURE $71.50
- Technical
- Relative Strength Index (RSI)
- ENIC 52.51
- QURE 36.57
- Support Level
- ENIC $3.81
- QURE $25.24
- Resistance Level
- ENIC $4.01
- QURE $31.16
- Average True Range (ATR)
- ENIC 0.11
- QURE 3.74
- MACD
- ENIC 0.00
- QURE -2.28
- Stochastic Oscillator
- ENIC 61.04
- QURE 16.43
About ENIC Enel Chile S.A. (Each representing 50 shares of)
Enel Chile SA is an electricity utility company, which through its subsidiaries and affiliates is engaged in the generation, transmission and distribution of electricity businesses in Chile. It operates through two segments including Generation Business and Distribution and Network Business. The Generation Business Segment is comprised of a group of electricity companies that own electricity generating plants, whose energy is transmitted and distributed to end customers. The Distribution and Network Reportable Segment is comprised of a group of electricity companies operating under a public utility concession.
About QURE uniQure N.V.
uniQure NV is a gene therapy company. It develops treatments and platforms for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases. The company is focused on the development of the pipeline of gene therapies with the collaboration of Bristol Myers Squibb for cardiovascular diseases.